Amphastar Pharma (AMPH) Stock Price, Quote, News & History | Benzinga

Amphastar Pharmaceuticals Inc (AMPH) Stock Price, Quote, News & History

AMPHNASDAQ

Trade with Public

Trade with Public

$21.60

-0.08-0.37%

At close: Aug 21, 5:00 PM EST

$21.60

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$21.64

Close

$21.60

Volume / Avg.

376.56K / 546.74K

Day Range

$21.44 - $22.20

52 Wk Range

16.65 - 31.26

Market Cap

$918.82M

P/E Ratio

12.83

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

25.25%

Days to Cover

11.89

Recent Amphastar Pharmaceuticals, Inc. News

Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

Trump sets a 2-year ultimatum for generic drugmakers to reshore U.S. production or face tariffs up to 200%.

Stjepan Kalinic

Crude Oil Gains 2%; Comcast Shares Spike Higher

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Monday. The Dow traded up 0.44% to 52,105.66 while the NASDAQ rose 1.33% to 25,634.54. The S&P 500 also

Avi Kapoor

This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrades, and initiations on analyst ratings page.

Avi Kapoor

This Whirlpool Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Analysts downgraded DOCS, MWH, WHR, AMPH, and WIX and lowered price targets. See how analysts view these stocks. Considering WHR stock? See analyst opinions.

Avi Kapoor

This HubSpot Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday

Wall Street analysts changed outlook on top names. Check all changes on analyst ratings page. See what analysts think about HUBS stock.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

184.61M

Investing Cash Flow (TTM)

-52.05M

Financing Cash Flow (TTM)

-96.46M

Free Cash Flow (TTM)

152.89M

Capital Expenditure (TTM)

-31.72M

Net Change in Cash (TTM)

36.10M

Analyst Trends and Forecast

2

Feb

1

Apr

2

May

1

1

Jun

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.3

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.32B

PE Ratio (TTM)

12.83

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.38

PB Ratio (TTM)

1.20

Earnings Yield % (TTM)

7.79%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

6.85

Price / EBITDA (TTM)

5.22

Price / Free Cash Flow (TTM)

6.58

Book Value / Share

$18.06

Company Debt

Total Debt

$612.05M

LT Debt

$609.56M

LT Debt Issuance (TTM)

$445.00K

LT Debt Repayment (TTM)

-$702.00K

Total Cash

$223.61M

Debt to Equity

0.90

Issuance of Debt (TTM)

-$257.00K

Repayment of Debt (TTM)

-$702.00K

Key Statistics

Open

$21.64

Close

$21.60

Volume / Avg.

376.56K / 546.74K

Day Range

$21.44 - $22.20

52 Wk Range

16.65 - 31.26

Market Cap

$918.82M

P/E Ratio

12.83

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

25.25%

Days to Cover

11.89

About

Sector

Health Care

Industry

Pharmaceuticals

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pha...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Amphastar Pharma (AMPH) stock?

A

You can purchase shares of Amphastar Pharma (NASDAQ:AMPH) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Amphastar Pharma (AMPH) competitors?

A

Other companies in Amphastar Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Amphastar Pharma (AMPH) stock?

A

Amphastar Pharma has a consensus price target of $28.13.

Q

What is the current price for Amphastar Pharma (AMPH)?

A

The stock price for Amphastar Pharma (NASDAQ: AMPH) is $21.6 last updated August 21, 2026 at 4:00 PM EDT.

Q

Does Amphastar Pharma (AMPH) pay a dividend?

A

There are no upcoming dividends for Amphastar Pharma.

Q

When is Amphastar Pharma (NASDAQ:AMPH) reporting earnings?

A

Amphastar Pharma does not have any upcoming earnings scheduled.

Q

Is Amphastar Pharma (AMPH) going to split?

A

There is no upcoming split for Amphastar Pharma.

Q

What sector and industry does Amphastar Pharma (AMPH) operate in?

A

Amphastar Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.